• Hugh D Moulding, David P Friedman, Mark Curtis, Lawrence Kenyon, Adam E Flanders, Sun Ha Paek, and David W Andrews.
• Department of Neurological Surgery, Thomas Jefferson University, 909 Walnut Street, Suite 200, Philadelphia, PA 19107, USA.
• J Magn Reson Imaging. 2008 Dec 1; 28 (6): 1311-21.

PurposeTo study whether anaplastic astrocytomas that are nonenhancing and/or well-circumscribed (expansive) are associated with a better prognosis.Materials And MethodsWe retrospectively identified 59 patients with pathologically confirmed World Health Organizaiton (WHO) grade III anaplastic astrocytoma who underwent craniotomy at our institution from 1995 through 2006. We assessed prognostic variables including age, enhancement (EAA-34 patients) vs. nonenhancement (NEAA-25 patients), MR growth patterns (expansive [28 patients] vs. mixed/infiltrative [31 patients]), recursive partitioning analysis (RPA) class, resection extent, and addition of chemotherapy. Primary outcome measure was survival.ResultsKaplan-Meier curves showed improved survival in NEAA, expansive tumors, and RPA 1 class patients. Within RPA class I patients, expansive growth pattern remained a significant advantage in survival time. Examining extent of resection also showed that patients with gross total resections (GTR) had a better prognosis. A multivariate (Cox proportional hazards) analysis showed that patient age and expansive tumor phenotype affected outcome, whereas RPA class, enhancement, and GTR did not.ConclusionCircumscribed growth in histologically proven anaplastic astrocytoma, which has not been emphasized in past studies, has a considerable survival advantage.(c) 2008 Wiley-Liss, Inc.

25 keywords...

hide…